572 related articles for article (PubMed ID: 29375465)
1. Application of Metabolomics in Alzheimer's Disease.
Wilkins JM; Trushina E
Front Neurol; 2017; 8():719. PubMed ID: 29375465
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease.
Gao C; Shen X; Tan Y; Chen S
J Neuroinflammation; 2022 Sep; 19(1):215. PubMed ID: 36058959
[TBL] [Abstract][Full Text] [Related]
3. Omics-based biomarkers discovery for Alzheimer's disease.
Aerqin Q; Wang ZT; Wu KM; He XY; Dong Q; Yu JT
Cell Mol Life Sci; 2022 Nov; 79(12):585. PubMed ID: 36348101
[TBL] [Abstract][Full Text] [Related]
4. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.
Hampel H; Nisticò R; Seyfried NT; Levey AI; Modeste E; Lemercier P; Baldacci F; Toschi N; Garaci F; Perry G; Emanuele E; Valenzuela PL; Lucia A; Urbani A; Sancesario GM; Mapstone M; Corbo M; Vergallo A; Lista S;
Ageing Res Rev; 2021 Aug; 69():101346. PubMed ID: 33915266
[TBL] [Abstract][Full Text] [Related]
5. Metabolic disorder in Alzheimer's disease.
Poddar MK; Banerjee S; Chakraborty A; Dutta D
Metab Brain Dis; 2021 Jun; 36(5):781-813. PubMed ID: 33638805
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the application of metabolomics to Alzheimer's Disease.
Trushina E; Mielke MM
Biochim Biophys Acta; 2014 Aug; 1842(8):1232-9. PubMed ID: 23816564
[TBL] [Abstract][Full Text] [Related]
7. Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer's Disease.
Dai Z; Hu T; Su S; Liu J; Ma Y; Zhuo Y; Fang S; Wang Q; Mo Z; Pan H; Fang J
Front Pharmacol; 2022; 13():904857. PubMed ID: 35694256
[TBL] [Abstract][Full Text] [Related]
8. Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products.
Yi L; Liu W; Wang Z; Ren D; Peng W
Ann N Y Acad Sci; 2017 Jun; 1398(1):130-141. PubMed ID: 28632966
[TBL] [Abstract][Full Text] [Related]
9. Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development.
Peña-Bautista C; Baquero M; Vento M; Cháfer-Pericás C
Curr Neuropharmacol; 2019; 17(7):630-647. PubMed ID: 30255758
[TBL] [Abstract][Full Text] [Related]
10. Integrative metabolomics science in Alzheimer's disease: Relevance and future perspectives.
Lista S; González-Domínguez R; López-Ortiz S; González-Domínguez Á; Menéndez H; Martín-Hernández J; Lucia A; Emanuele E; Centonze D; Imbimbo BP; Triaca V; Lionetto L; Simmaco M; Cuperlovic-Culf M; Mill J; Li L; Mapstone M; Santos-Lozano A; Nisticò R
Ageing Res Rev; 2023 Aug; 89():101987. PubMed ID: 37343679
[TBL] [Abstract][Full Text] [Related]
11. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
Castrillo JI; Lista S; Hampel H; Ritchie CW
Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in Sporadic and Familial Alzheimer's Disease.
Lista S; O'Bryant SE; Blennow K; Dubois B; Hugon J; Zetterberg H; Hampel H
J Alzheimers Dis; 2015; 47(2):291-317. PubMed ID: 26401553
[TBL] [Abstract][Full Text] [Related]
13. Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?
Yin C; Harms AC; Hankemeier T; Kindt A; de Lange ECM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902391
[TBL] [Abstract][Full Text] [Related]
14. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
[TBL] [Abstract][Full Text] [Related]
15. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
[TBL] [Abstract][Full Text] [Related]
16. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
Horgusluoglu E; Neff R; Song WM; Wang M; Wang Q; Arnold M; Krumsiek J; Galindo-Prieto B; Ming C; Nho K; Kastenmüller G; Han X; Baillie R; Zeng Q; Andrews S; Cheng H; Hao K; Goate A; Bennett DA; Saykin AJ; Kaddurah-Daouk R; Zhang B; ;
Alzheimers Dement; 2022 Jun; 18(6):1260-1278. PubMed ID: 34757660
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer's risk factors among 1,111 cohort participants.
Darst BF; Lu Q; Johnson SC; Engelman CD
Genet Epidemiol; 2019 Sep; 43(6):657-674. PubMed ID: 31104335
[TBL] [Abstract][Full Text] [Related]
18. The application of lipidomics to biomarker research and pathomechanisms in Alzheimer's disease.
Wong MW; Braidy N; Poljak A; Sachdev PS
Curr Opin Psychiatry; 2017 Mar; 30(2):136-144. PubMed ID: 28002106
[TBL] [Abstract][Full Text] [Related]
19. Proteomics and metabolomics characterizing the pathophysiology of adaptive reactions to the metabolic challenges during the transition from late pregnancy to early lactation in dairy cows.
Ceciliani F; Lecchi C; Urh C; Sauerwein H
J Proteomics; 2018 Apr; 178():92-106. PubMed ID: 29055723
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
